Krka has looked to brush aside any concerns that it will run into capacity constraint issues in the near term, as it continues to eye revenue growth of around 6% or more in 2025 to reach its group sales target of surpassing the €2bn ($2.08bn) mark for the first time in the company’s history.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?